Related Experiment Video
Updated: Jan 15, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
A Sodium Iron Phosphate Nanocatalyst-Regulated High-Mobility Ion Reservoir Enables Tumor-Selective Immunotherapy
Zitong Zhu1,2, Huan Wang1, Mengmeng Liu1,2
1State Key Laboratory of Rare Earth Resource Utilization and Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
Abstract:
Sodium ion (Na+)-mediated pyroptosis has emerged as a promising strategy in ion interference therapy (IIT) for tumor treatment. However, conventional Na+ delivery systems suffer from off-target leakage and osmotic toxicity in normal tissues. Herein, we present the construction of a peroxidase-mimicking ion reservoir based on sodium iron phosphate (NFPP) nanocatalysts, which enables rapid and tumor-selective Na+ outflow through pH-gated nanocatalytic activation. NFPP maintains an "OFF" state in normal cells due to the minimal ion release induced by the catalytic inactivation. Crucially, in tumor cells, the peroxidase-like catalytic activity of NFPP is activated by the more acidic lysosome environment than that within normal cells, transitioning NFPP to an "ON" state. The optimal activity boosts the Na+ outward migration, resulting in intracellular Na+ overload that triggers the pyroptosis pathway. Conversely, the rapid Na+ flux amplifies the peroxidase-like catalytic activity, thus reinforcing oxidative stress and exacerbating pyroptosis. The NFPP nanoplatform can further provoke robust immune responses and provide long-term protection against tumor relapse and metastasis. This work pioneers a design strategy for constructing nanocatalysis-regulated high-mobility ion reservoirs to overcome limitations in precise ion modulation for selective tumor immunotherapy.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...

